Natera Executive Sells $528K in Stock to Cover RSU Taxes, Shares Remain Substantial
Solomon Moshkevich, Natera's President of Clinical Diagnostics, executed two planned sales totaling 2,213 shares of NTRA common stock to satisfy tax obligations tied to vested restricted stock units. The transactions, carried out under a Rule 10b5-1 plan on January 27 and 28, 2026, generated roughly $528,853 in proceeds at prices modestly above the…